ABC | Volume 111, Nº5, Novembro 2018

Artigo Original Serpytis et al Ansiedade e depressão após infarto do miocárdio Arq Bras Cardiol. 2018; 111(5):676-683 18. vanMelle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression followingmyocardial infarction withmortality and cardiovascular events: ameta-analysis. PsychosomMed. 2004;66(6):814-22. 19. Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived stress in myocardial infarction: long-termmortality and health status outcomes. J Am Coll Cardiol. 2012;60(18):1756-63. 20. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, et al. Evenminimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88(4):337-41. 21. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure- Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350-69. 22. Mendes de Leon CF, Krumholz HM, Seeman TS, Vaccarino V, Williams CS, Kasl SV, et al. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Established Populations for the Epidemiologic Studies of the Elderly. Arch Intern Med. 1998;158(21):2341-8. 23. Larsen KK, Christensen B, Nielsen TJ, Vestergaard M. Post-myocardial infarction anxiety or depressive symptoms and risk of new cardiovascular events or death: a population-based longitudinal study. Psychosom Med. 2014;76(9):739-46. 24. Hosseini SH, Ghaemian A, Mehdizadeh E, Ashraf H. Contribution of depression and anxiety to impaired quality of life in survivors of myocardial infarction. Int J Psychiatry Clin Pract. 2014;18(3):175-81. 25. SmeijersL,MostofskyE,ToflerGH,MullerJE,KopWJ,MittlemanMA.Anxiety andanger immediatelypriortomyocardial infarctionand long-termmortality: Characteristics of high-risk patients. J PsychosomRes. 2017;93:19-27. 26. Paine NJ, Bacon SL, Pelletier R, Arsenault A, Diodati JG, Lavoie KL. Do Womenwith anxiety or depression have higher rates of myocardial ischemia duringexercisetestingthanmen?CircCardiovascQualOutcomes.2016;9(2 Suppl 1):S53-61. 27. Halvorsen S, Eritsland J, Abdelnoor M, Holst Hansen C, Risoe C, Midtbo K, et al. Gender differences inmanagement and outcome of acutemyocardial infarctions treated in 2006-2007. Cardiology. 2009;114(2):83-8. 28. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-53. 29. Engel DF, de Oliveira J, Lopes JB, Santos DB, Moreira ELG, Farina M, et al. Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-/-) mouse experimental model. Behav Brain Res. 2016 Sep 15;311:31-8. 30. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005;165(21):2508-13. 31. Di Matteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-7. 32. Swenson JR. Quality of life in patients with coronary artery disease and the impact of depression. Curr Psychiatry Rep. 2004;6(6):438-45. 33. Rodrigues GH, Gebara OC, Gerbi CC, Pierri H, Wajngarten M. Depression as a clinical determinant of dependence and low quality of life in elderly patients with cardiovascular disease. Arq Bras Cardiol. 2015;104(6):443-9. 34. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res. 2000;48(4-5):471-8. 35. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the AmericanHeart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768-75. 36. HaddadM,Walters P, Phillips R, Tsakok J,Williams P, Mann A, et al. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One. 2013;8(10):e78493. 37. Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R. Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life Outcomes. 2013;11:37. 38. HareDL,ToukhsatiSR,JohanssonP,JaarsmaT.Depressionandcardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-72. 39. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svardsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med. 2011;171(2):134-40. 40. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003;92(11):1277-81. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 683